Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials.

Min-Tsun LiaoMeng-Kan ChenMu-Yang HsiehNai-Lun YehKuo-Liong ChienChih-Ching LinChih-Cheng WuWei-Chu Chie

Published in: PloS one (2020)

DCB angioplasty did not demonstrate significant patency benefit for the treatment of hemodialysis vascular access dysfunction. Wide variations in patency outcomes across studies were noted. Further studies focusing on specific types of access or lesions are warranted to clarify the value of DCB for hemodialysis vascular access. (PROSPERO Number CRD42019119938).

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
case control
oxidative stress
emergency department
skeletal muscle
metabolic syndrome
drug induced